Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production
- 1 July 1998
- journal article
- review article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 79 (1) , 75-82
- https://doi.org/10.1016/s0301-2115(98)00050-5
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Age at menopause as a risk factor for cardiovascular mortalityThe Lancet, 1996
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- Reduction of cardiovascular disease—related mortality among postmenopausal women who use hormones: Evidence from a national cohortAmerican Journal of Obstetrics and Gynecology, 1991
- Estrogen Replacement and Coronary Artery DiseaseArchives of internal medicine (1960), 1990
- Mortality in a cohort of long‐term users of hormone replacement therapy: an updated analysisBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Risk factors and noncontraceptive estrogen use in women with and without coronary diseaseAmerican Heart Journal, 1989
- Estrogen replacement therapy and protection from acute myocardial infarctionAmerican Journal of Obstetrics and Gynecology, 1988
- Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.Circulation, 1987
- Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham populationPublished by Elsevier ,1986
- Menopause and Risk of Cardiovascular DiseaseAnnals of Internal Medicine, 1976